NCT03584334View on ClinicalTrials.gov

18FDG PET for Early Identification of Tumor Exhaust for Immunotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Bronchopulmonary Carcinoma or Melanoma

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 4, 2019

Primary Completion Date

June 26, 2024

Study Completion Date

June 26, 2024

Conditions
Non-Small Cell Bronchopulmonary Carcinoma or Melanoma
Interventions
RADIATION

18FDG PET

Diagnostic performance of 18FDG PET for identification of early tumor escape to immunotherapy in patients with unresectable melanoma or Broncho-Pulmonary Carcinoma No to Advanced or Metastatic Small Cells

Trial Locations (1)

06189

Centre Antoine Lacassagne, Nice

All Listed Sponsors
lead

Centre Antoine Lacassagne

OTHER

NCT03584334 - 18FDG PET for Early Identification of Tumor Exhaust for Immunotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Bronchopulmonary Carcinoma or Melanoma | Biotech Hunter | Biotech Hunter